Cosmos Health issues 2026-2029 guidance targeting $200m revenue by 2029

Cosmos Health Inc. (NASDAQ: COSM) announced financial guidance projecting revenue growth to $200.6 million by 2029, representing a 207% increase from $65.3 million in 2025. The diversified healthcare company expects to achieve profitability in 2027.

The guidance includes gross profit expanding to $71.2 million by 2029, up from $7.9 million in 2025, with gross margins improving from 12.1% to 35.5%. Net income is projected to reach $31.0 million by 2029, compared to a net loss of $19.1 million in 2025.

Cosmos Health expects adjusted EBITDA to grow from negative $3.4 million in 2025 to $44.2 million by 2029. Operating cash flow is projected to turn positive in 2027 at $11.9 million and increase to $24.0 million by 2029.

The company anticipates cash and cash equivalents rising to $62.9 million by 2029 from $3.5 million in 2025. All convertible notes are expected to be repaid, with stockholders' equity projected to increase 402% to $92.3 million.

Chief Executive Officer Greg Siokas stated the company is targeting higher-margin proprietary products and business segments. The growth strategy includes expanding pharmaceutical distribution, U.S. nutraceutical commercialization, international expansion of Sky Premium Life products, and contract manufacturing scale-up at Cana Laboratories.

The company operates through multiple segments including pharmaceutical distribution via Cosmofarm, manufacturing through Cana Laboratories, and proprietary products including the 18 Series nutraceuticals and C-Scrub antimicrobial cleanser. Cosmos Health also has research and development initiatives including AI-driven drug repurposing and nanotechnology programs.

The guidance assumes continued growth across all core segments and includes expectations for selective acquisitions and business combinations to complement organic growth initiatives.

You May Also Be Interested In

• ADARx Pharmaceuticals files for proposed IPO
• USA Rare Earth (USAR) files $1.25B mixed shelf
• DTE Energy board director David Thomas to retire after 13 years